Dr. Antonio Passaro (MD, PhD) is a Senior Staff Physician with High Specialisation at the Division of Thoracic Oncology, European Institute of Oncology (IEO) in Milan, Italy, with a PhD in molecular medicine. His clinical and research expertise centres on targeted therapies and immunotherapy in non-small cell lung cancer (NSCLC), with a focus on predictive biomarkers and driver alterations. An active ESMO faculty member for Lung and other Thoracic Tumours since 2019, he served as Chair of the ESMO Press and Media Affairs Committee from 2021 to 2024, and is Associate Editor of the Lung Cancer Journal (Elsevier, from 2022). He has authored more than 170 peer-reviewed publications and is actively involved in translational research and clinical trials in thoracic oncology.